[Clinical development of an anti-arrhythmic. Human electrophysiology]. 1986

C Libersa, and J Caron, and J Lekieffre

UI MeSH Term Description Entries
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic

Related Publications

C Libersa, and J Caron, and J Lekieffre
January 1978, Kardiologia polska,
C Libersa, and J Caron, and J Lekieffre
February 2006, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
C Libersa, and J Caron, and J Lekieffre
January 1987, Archivos del Instituto de Cardiologia de Mexico,
C Libersa, and J Caron, and J Lekieffre
January 1999, Indian journal of clinical biochemistry : IJCB,
C Libersa, and J Caron, and J Lekieffre
July 2002, Nihon rinsho. Japanese journal of clinical medicine,
C Libersa, and J Caron, and J Lekieffre
March 1998, Expert opinion on investigational drugs,
C Libersa, and J Caron, and J Lekieffre
January 1974, Archivio "E. Maragliano" di patologia e clinica,
C Libersa, and J Caron, and J Lekieffre
May 1975, Minerva medica,
C Libersa, and J Caron, and J Lekieffre
January 1969, Naika. Internal medicine,
C Libersa, and J Caron, and J Lekieffre
July 1985, Yao xue xue bao = Acta pharmaceutica Sinica,
Copied contents to your clipboard!